| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31.9M | +137.0% | — |
| R&D Expense | $186K | +654.8% | +1141.1% |
| SG&A Expense | $1.3M | -43.2% | -76.2% |
| Operating Income | -$2.2M | +20.7% | +60.6% |
| Pre-tax Income | -$2.2M | +48.4% | +83.5% |
| Income Tax | $0 | — | — |
| Net Income | -$2.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $31K | -68.6% | -77.2% |
| Accounts Receivable | $1.0M | +142.1% | +2554.6% |
| Current Assets | $1.3M | -21.6% | -50.2% |
| Total Assets | $16.1M | +21.4% | +43.0% |
| Current Liabilities | $5.5M | -15.9% | +24.2% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.1M | — | — |
| Investing Cash Flow | -$400K | — | — |
| Financing Cash Flow | $2.0M | — | — |
| +83.7% |
| EPS (Basic) | -$0.10 | +54.5% | +96.2% |
| EPS (Diluted) | -$0.10 | +54.5% | +96.2% |
| $0 |
| -100.0% |
| — |
| Total Liabilities | $5.5M | -15.9% | +24.2% |
| Stockholders' Equity | $10.4M | +58.6% | +52.3% |